Results 151 to 160 of about 58,993,052 (257)

Integrated spherical nucleic acid nanoreactor mobilizes targeted PD‐L1 proteolysis and cuproptosis for robust breast cancer immunotherapy

BMEMat, EarlyView.
This study provides an integrated spherical nucleic acid nanoreactor (denoted as AMCuD) for targeted PD‐L1 degradation and chemo‐dynamically enhanced cuproptosis to synergically elicit robust immunotherapy against the triple‐negative breast cancer (TNBC) growth, recurrence and metastasis.
Ningxi Li, Honglin Huang, Qianyi Zeng, Li Zeng, Ziman Yang, Jinyang Shen, Shun Li, Hong Yang, Yiyao Liu, Chunhui Wu   +9 more
wiley   +1 more source

[Female sexual function in breast cancer referred at the tertiary level]. [PDF]

Rev Med Inst Mex Seguro Soc
Romo-Aguirre CM, Toro-Sashida MF, González-Ojeda A, Hernández-Ramírez VT, Gómez-Sierra JP, Villaseñor-Rodríguez AR, Fuentes-Orozco C.   +6 more
europepmc   +1 more source

Programmable three‐state nanoreactor for spatiotemporally controlled tumor therapy

BMEMat, EarlyView.
The OMVs are shielded with a biocompatible Da–Ca shell, which prolongs its circulation period and promotes intratumoral accumulation. Importantly, the biocompatible Da–Ca shell can be controllably disintegrated in tumor microenvironment by using laser irradiation, generating in situ hyperthermia and releasing Ca2+.
Guihong Lu, Peng Ye, Xiaoyan Li, Ke Ma, Chengliang Lyu, Kai Zhang, Ran Luo, Yang Ji, Shiqi Mei, Fan Zhang, Jinxie Zhang, Lin Mei, Hui Tan   +12 more
wiley   +1 more source

[Infrared thermography outcomes in women with suspected breast cancer]. [PDF]

Rev Med Inst Mex Seguro Soc
Luna-Patiño GA, Sosa-Bustamante GP, Ibarra-Morán DL, Gallegos-Ríos VM, León-Zamudio JA, Luna-Anguiano JLF, Paque-Bautista C, González AP.   +7 more
europepmc   +1 more source

Construction and validity of a storyboard about breast cancer for women deprived of liberty. [PDF]

Rev Bras Enferm, 2023
Galiza DDF, Cabral LA, Lima DER, Sampaio HAC.   +3 more
europepmc   +1 more source

Tailoring drug‐to‐lipid ratio in redox‐responsive lipid‐mimetic prodrug liposomes for superior cabazitaxel delivery and antitumor efficacy

BMEMat, EarlyView.
Redox‐responsive lipid‐mimetic prodrug liposomes with high drug‐to‐lipid ratios enhance cabazitaxel delivery, prolong circulation, and enable tumor‐selective drug release for superior antitumor efficacy and safety. Abstract Liposomes represent one of the most extensively investigated nanocarriers in drug delivery.
Shengyao Xu, Danping Wang, Si Zheng, Zhiyu Kuang, Ya Gao, Haiyu Zhao, Lurong Zhang, Jiayu Guo, Jingyi Zhang, Weiyao Li, Anhua Wang, Hongrui Lei, Zhonggui He, Ken‐ichiro Kamei, Jianzhao Niu, Lingyun Ma, Bingjun Sun   +16 more
wiley   +1 more source

[Clinicopathological characteristics of human epidermal growth factor receptor-2 1+ cases in breast cancer]. [PDF]

Rev Med Inst Mex Seguro Soc
Sánchez-Corona Y, Quiñonez-Urrego EE.
europepmc   +1 more source

[Cognitive deficits with chemotherapy in women with breast cancer: a bibliographic revisión] [PDF]

Rev Fac Cien Med Univ Nac Cordoba, 2023
Arce B, Grañana N.
europepmc   +1 more source

RNA‐centric world of retroviruses: unravelling the molecular strategies of genomic RNA packaging

Biological Reviews, EarlyView.
ABSTRACT Retroviruses constitute a unique group of RNA viruses that have profoundly influenced both evolutionary trajectories and biomedical research. Their ability to reverse transcribe and integrate into host genomes has shaped genomic architecture across species and contributed to our understanding of oncogenes, gene regulation, and RNA biology ...
Mohammad Abdullah Jehad, Suresha G. Prabhu, Lizna M. Ali, Vineeta N. Pillai, Farah Mustafa, Tahir A. Rizvi   +5 more
wiley   +1 more source

[Fear of cancer recurrence and primary care utilization in women with breast cancer]. [PDF]

Aten Primaria
Garduño-Sánchez S, Iglesias-Melero C, Carrasco-Sánchez FJ, Gómez-Salgado J.   +3 more
europepmc   +1 more source